People · Operator
Named in public records as an officer, director or promoter · active 2015–2022 · Pharmaceuticals, Other Technology, Pharma, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Metacrine, Inc. | — | Pharmaceuticals | Series C | $124.8M | $2.3B | 2015 |
| Shiftboard, Inc | — | Other Technology | Series A | $24.1M | $221.5M | 2020 |
| Seal Rock Therapeutics, Inc. | — | Pharma | Seed | $2.5M | $42.4M | 2022 |
| Freshlocal Solutions Inc. | — | Retailing | Pre-Seed | $357K | $1.7M | 2022 |
Neil McDonnell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Neil McDonnell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Brown | 1 | 34 |
| Kristina Burow | 1 | 16 |
| Amir Nashat | 1 | 14 |
| Erik Benson | 1 | 13 |
| Clete Brewer | 1 | 8 |
| Carol Gallagher | 1 | 6 |
| Robert Adelman | 1 | 5 |
| Annette Eyraud | 1 | 3 |
| Monique Wilberg | 1 | 3 |
| Monika Russell | 1 | 2 |
| Carl Albrecht | 1 | 2 |
| Ken Song | 1 | 2 |
| Robert Eleveld | 1 | 2 |
| Richard Heyman | 1 | 2 |
| Douglas Harrison | 1 | 2 |
| Ronald Evans | 1 | 2 |
| Trisha Millican | 1 | 2 |
| Kenneth Song | 1 | 2 |
| Ian Herbert-Jones | 1 | 2 |
| Tamara Turner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.